These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9026655)

  • 1. Analysis of inhibition of retroviral reverse transcriptase.
    Balzarini J; De Clercq E
    Methods Enzymol; 1996; 275():472-502. PubMed ID: 9026655
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
    J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases.
    Chen H; Brown D; Gold L
    Methods Enzymol; 1996; 275():503-20. PubMed ID: 9026656
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase.
    Rodríguez-Barrios F; Pérez C; Lobatón E; Velázquez S; Chamorro C; San-Félix A; Pérez-Pérez MJ; Camarasa MJ; Pelemans H; Balzarini J; Gago F
    J Med Chem; 2001 Jun; 44(12):1853-65. PubMed ID: 11384232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity.
    Lingham RB; Hsu AH; O'Brien JA; Sigmund JM; Sanchez M; Gagliardi MM; Heimbuch BK; Genilloud O; Martin I; Diez MT; Hirsch CF; Zink DL; Liesch JM; Koch GE; Gartner SE; Garrity GM; Tsou NN; Salituro GM
    J Antibiot (Tokyo); 1996 Mar; 49(3):253-9. PubMed ID: 8626240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors.
    Divita G; Baillon JG; Rittinger K; Chermann JC; Goody RS
    J Biol Chem; 1995 Dec; 270(48):28642-6. PubMed ID: 7499382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors.
    Yang G; Song Q; Charles M; Drosopoulos WC; Arnold E; Prasad VR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):326-33. PubMed ID: 8601218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs.
    Kissel JD; Held DM; Hardy RW; Burke DH
    AIDS Res Hum Retroviruses; 2007 May; 23(5):699-708. PubMed ID: 17530996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A minor groove binding track in reverse transcriptase.
    Bebenek K; Beard WA; Darden TA; Li L; Prasad R; Luton BA; Gorenstein DG; Wilson SH; Kunkel TA
    Nat Struct Biol; 1997 Mar; 4(3):194-7. PubMed ID: 9164459
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors.
    Romeo R; Giofrè SV; Macchi B; Balestrieri E; Mastino A; Merino P; Carnovale C; Romeo G; Chiacchio U
    ChemMedChem; 2012 Apr; 7(4):565-9. PubMed ID: 22323191
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
    Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
    Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
    Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment.
    Clark AD; Jacobo-Molina A; Clark P; Hughes SH; Arnold E
    Methods Enzymol; 1995; 262():171-85. PubMed ID: 8594346
    [No Abstract]   [Full Text] [Related]  

  • 16. Assays for retroviral reverse transcriptase.
    Telesnitsky A; Blain S; Goff SP
    Methods Enzymol; 1995; 262():347-62. PubMed ID: 8594360
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
    Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
    Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The processivity of DNA synthesis exhibited by drug-resistant variants of human immunodeficiency virus type-1 reverse transcriptase.
    Avidan O; Hizi A
    Nucleic Acids Res; 1998 Apr; 26(7):1713-7. PubMed ID: 9512543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer.
    Perach M; Rubinek T; Hughes SH; Hizi A
    J Mol Biol; 1997 May; 268(3):648-54. PubMed ID: 9171288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutagenic analysis of viral polymerases and related proteins.
    Boyer PL; Hughes SH
    Methods Enzymol; 1996; 275():538-55. PubMed ID: 9026658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.